Alternative Splicing of Cyclooxygenase-1 mRNA in the Human Iris
Authors:
- Melloney J. DrögeMDMelloney J. Dröge
- Adriaan A. van SorgeASAdriaan A. van Sorge
- Nicolaas J. van HaeringenNHNicolaas J. van Haeringen
- Wim J. QuaxWim J. Quax
- Johan ZaagsmaJZJohan Zaagsma
- 25 April 2003
- journal article
- Published by S. Karger AG in Ophthalmic Research
- Vol. 35 (3) , 160-163
Abstract
In homogenates of the human iris, the nonsteroidal anti-inflammatory drug (NSAID) S(+)flurbiprofen has been reported to inhibit cyclooxygenase-1 (COX-1) 70-fold more potently than in human whole blood. We hypothesized that this difference may be due to alternative splicing of COX-1 mRNA in the human iris or in whole blood. In this study, we have identified a similar COX-1 splice variant (COX-1SV) in both tissues with comparable COX-1/COX-1SV expression ratios. Therefore, we conclude that the difference in IC50 values of S(+)flurbiprofen towards COX-1 in the human iris and human whole blood is not related to differences in the occurrence of spliced COX-1.Keywords
This publication has 3 references indexed in Scilit:
- Alternative splicing: multiple control mechanisms and involvement in human diseaseTrends in Genetics, 2002
- Molecular characterization of the 5.2 KB isoform of the human cyclooxygenase-1 transcriptProstaglandins, 1996
- Arachidonic Acid MetabolismAnnual Review of Biochemistry, 1986